Last 13.50 INR
Change Today 0.00 / 0.00%
Volume 0.0
MDCB On Other Exchanges
Symbol
Exchange
Mumbai
As of 10:14 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

medicamen biotech ltd (MDCB) Snapshot

Open
12.34
Previous Close
12.34
Day High
13.50
Day Low
12.34
52 Week High
09/15/14 - 19.25
52 Week Low
12/24/13 - 6.40
Market Cap
120.3M
Average Volume 10 Days
281.3
EPS TTM
-1.00
Shares Outstanding
8.9M
EX-Date
09/21/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAMEN BIOTECH LTD (MDCB)

Related News

No related news articles were found.

medicamen biotech ltd (MDCB) Related Businessweek News

No Related Businessweek News Found

medicamen biotech ltd (MDCB) Details

Medicamen Biotech Limited manufactures and markets pharmaceutical formulations in India and internationally. It offers pharmaceutical products in the form of tablets, capsules, liquid and dry syrups, ointment, and ORS. The company was incorporated in 1993 and is based in New Delhi, India.

Founded in 1993

medicamen biotech ltd (MDCB) Top Compensated Officers

Founder, Managing Director, Director and Memb...
Total Annual Compensation: 5.0M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 2.3M
Whole-Time Director and Member of Quality Ass...
Total Annual Compensation: 503.2K
Compensation as of Fiscal Year 2014.

medicamen biotech ltd (MDCB) Key Developments

Medicamen Biotech Ltd. Approves Executive Changes

Medicamen Biotech Ltd. at its Board of Directors Meeting held on October 09, 2014, approved the resignation of Mrs. Sharmila Chhikara, Company Secretary & Compliance Officer, withe effect from October 09, 2014 and appointed Ms. Kiran as Company Secretary & Compliance October 10, 2014.

Medicamen Biotech Ltd., Board Meeting, Oct 09, 2014

Medicamen Biotech Ltd., Board Meeting, Oct 09, 2014. Agenda: To consider general things; to consider and approve resignation of Sharmila Chhikara, Company Secretary & Compliance Officer, with effect from October 09, 2014; and to approve the appointment of Ms. Kiran as Company Secretary & Compliance October 10, 2014.

Medicamen Biotech Ltd., Annual General Meeting, Sep 30, 2014

Medicamen Biotech Ltd., Annual General Meeting, Sep 30, 2014., at 15:30 Indian Standard Time. Location: Shree Shah Auditorium, Gujrati Samaj, 2. Agenda: To receive, consider and adopt the audited balance sheet of the company as on March 31, 2014 and the profit and loss account for the year ended as on that date together with the reports of the auditors and directors thereon; to appoint a Director in place of Sh. Sanjay Bansal; to appoint M/s. Ashok Sharma & Associates, Chartered Accountants, as Auditors of the company; to exercise powers to the Board of Directors to contribute for the welfare of society to charitable institutions; to exercise powers to the Board of Directors to borrow by way of loan/debentures; to re-appoint Mr. Rajinder Kumar Gupta as an Independent Director of the company; to re-appoint Dr. Munishwar Lal Parnami as an Independent Director of the company; and to re-appoint Ms. Harshita as an Independent Director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCB:IN 13.50 INR 0.00

MDCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDCB.
View Industry Companies
 

Industry Analysis

MDCB

Industry Average

Valuation MDCB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 7.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAMEN BIOTECH LTD, please visit www.medicamen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.